ESHAP therapy effective in a patient with Langerhans cell sarcoma

International Journal of Hematology

Volumn 87, Issue 5, 2008, Pages 532-537

  Yoshimi, Akihide ^a   Kumano, Keiki ^a,b   Motokura, Toru ^a   Takazawa, Yutaka ^a   Oota, Satoshi ^a   Chiba, Shigeru ^a,b   Takahashi, Tsuyoshi ^a   Fukayama, Masashi ^a   Kurokawa, Mineo ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

Chemotherapy; ESHAP; Histiocytosis; Langerhans cell sarcoma; Positron emission tomography; Transplantation

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FLUORODEOXYGLUCOSE F 18; METHYLPREDNISOLONE; PREDNISOLONE; TACROLIMUS; VINCRISTINE;

ADULT; ANAMNESIS; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; DRUG EFFECT; ENDOSCOPIC BIOPSY; FEMALE; HEPATOSPLENOMEGALY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTENSIVE CARE; LANGERHANS CELL SARCOMA; LIVER FAILURE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MULTIPLE CYCLE TREATMENT; POSITRON EMISSION TOMOGRAPHY; SARCOMA; TREATMENT RESPONSE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FEMALE; HUMANS; LANGERHANS CELL SARCOMA; METHYLPREDNISOLONE; MIDDLE AGED; PREDNISONE; REMISSION INDUCTION; VINCRISTINE;

EID: 46149111680     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-008-0075-6     Document Type: Article

References (18)

1. Ben-Ezra J, Bailey A, Azumi N, et al. Malignant histiocytosis X. A distinct clinicopathologic entity. Cancer. 1991;68:1050-60.
2. Bohn OL, Ruiz-Arguelles G, Navarro L, Saldivar J, Sanchez-Sosa S. Cutaneous Langerhans cell sarcoma: a case report and review of the literature. Int J Hematol. 2007;85:116-20.
3. Diaz-Sarrio C, Salvatella-Danes N, Castro-Forns M, Nadal A. Langerhans cell sarcoma in a patient who underwent transplantation. J Eur Acad Dermatol Venereol. 2007;21:973-6.
4. Ferringer T, Banks PM, Metcalf JS. Langerhans cell sarcoma. Am J Dermatopathol. 2006;28:36-9.
5. Itoh H, Miyaguni H, Kataoka H, et al. Primary cutaneous Langerhans cell histiocytosis showing malignant phenotype in an elderly woman: report of a fatal case. J Cutan Pathol. 2001;28:371-8.
6. Julg BD, Weidner S, Mayr D. Pulmonary manifestation of a Langerhans cell sarcoma: case report and review of the literature. Virchows Arch. 2006;448:369-74.
7. Kawase T, Hamazaki M, Ogura M, et al. CD56/NCAM-positive Langerhans cell sarcoma: a clinicopathologic study of 4 cases. Int J Hematol. 2005;81:323-9.
8. Lee JS, Ko GH, Kim HC, Jang IS, Jeon KN, Lee JH. Langerhans cell sarcoma arising from Langerhans cell histiocytosis: a case report. J Korean Med Sci. 2006;21:577-80.
9. Misery L, Godard W, Hamzeh H, et al. Malignant Langerhans cell tumor: a case with a favorable outcome associated with the absence of blood dendritic cell proliferation. J Am Acad Dermatol. 2003;49:527-9.
10. Pileri SA, Grogan TM, Harris NL, et al. Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology. 2002;41:1-29.
11. Tani M, Ishii N, Kumagai M, Ban M, Sasase A, Mishima Y. Malignant Langerhans cell tumour. Br J Dermatol. 1992;126:398-403.
12. Wood C, Wood GS, Deneau DG, Oseroff A, Beckstead JH, Malin J. Malignant histiocytosis X. Report of a rapidly fatal case in an elderly man. Cancer. 1984;54:347-52.
13. McKelvey EM, Gottlieb JA, Wilson HE, et al. Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma. Cancer. 1976;38:1484-93.
14. Velasquez W, McLaughlin P, Tucker S, et al. ESHAP - an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study. J Clin Oncol. 1994;12:1169-76.
15. Honda R, Ohno Y, Iwasaki T, et al. Langerhans' cell histiocytosis after living donor liver transplantation: report of a case. Liver Transpl. 2005;11:1435-8.
16. Chu T. Langerhans cell histiocytosis. Australas J Dermatol. 2001;42:237-42.
17. Stockschlaeder M, Sucker C. Adult Langerhans cell histiocytosis. Eur J Haematol. 2006;76:363-8.
18. Akkari V, Donadieu J, Piguet C, et al. Hematopoietic stem cell transplantation in patients with severe Langerhans cell histiocytosis and hematological dysfunction: experience of the French Langerhans Cell Study Group. Bone Marrow Transplant. 2003;31:1097-103.